🔎 Trials Near Me

Home › Brain Diseases › Texas › Houston

Brain Diseases clinical trials in Houston, TX

6 studies for Brain Diseases are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

RecruitingPhase 2
  • Houston Methodist Hospital, Houston
  • The University of Texas Health Science Center at Houston, Houston
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

RecruitingPhase 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT05386108

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

RecruitingPhase 1
  • MD Anderson Cancer Center, Houston
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388

Study of Selected X-Linked Disorders: Aicardi Syndrome

RecruitingObservational study
  • Baylor College of Medicine, Houston
All ages · All sexes · Updated May 5, 2026 · NCT00697411

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

RecruitingObservational studyHealthy volunteers welcome
  • Baylor College of Medicine, Houston
All ages · All sexes · Updated Feb 4, 2026 · NCT01694940

Open-label Extension Study in Participants With Early Alzheimer's Disease

RecruitingPhase 2
  • GSK Investigational Site, Houston
Ages 50 to 85 · All sexes · Updated Feb 2, 2026 · NCT07105709

About Brain Diseases

Brain diseases affect different functions of the body from memory, speech, thinking clearly, how well the different organs work, or even movement.

More about Brain Diseases on MedlinePlus

Brain Diseases trials in other cities

Other studies in Houston

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.